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The Increasing Prevalence of Haemophilia
Dear Sir,
Treatment of haemophiha patients depends on an adequate
supply of blood products As long äs clottmg factor preparations
produced by recombmant DNA techmques are not widely avail-
able, changes m the number of patients may threaten the precious
balance of blood donations and plasma products consumption
The observed prevalence of haemophiha is the resultant of the
prevalence at birth and mortahty It may be affected by genetic
counsehng of carner women and selective abortion and also by
the fertility of patients Until only 20 years ago haemophiha
patients had a hfe expectancy less than 30 years (1), and therefore
the prevalence we observe today will be much smaller than the
prevalence at birth Nowadays, hfe expectancy is only mildly
reduced (2), aside from the present AIDS mortahty which differs
from country to country The present longevity of haemophiha
patients will therefore lead to an mcrease m their number
This is illustrated m Fig l, which shows the prevalence of
haemophiha per age group in The Netherlands These data were
obtamed by a survey of all registered 1,162 Dutch haemophiha
patients Information was available for 80% of the patients, the
prevalence date have been extended to all 1,162 In each age
group the number of patients m divided by the total number of
men m The Netherlands of that age (3) Up to age 20 (mid
mterval) the prevalence mcreases This is likely to be caused by
delays in diagnosis, mamly of mild haemophiha After age 40
(mid mterval), there is a steady declme of the age specific
prevalence This deficit of older patients can only be explamed by
excess mortahty in the past The plateau of 20 6 per 100,000 males
approximates the prevalence at birth If this prevalence were
present at all ages, the number of haemophiha patients would be
almost 1,500, i e 28% more than the present number of
haemophiha patients m The Netherlands
At the moment the mortahty m haemophiha is twice äs high äs
in the general population, aside from AIDS mortahty This leads,
äs calculated by hfe table method, to a reduction m the overall
prevalence of about 10% Prenatal diagnosis and selective abor-
tion might affect the prevalence at birth, this effect will be
minimal however, since we found m a recent survey of 549 female
relatives of haemophiha patients that only a minonty of carriers
choose for this Option (4), which corroborates reports from the
United Kingdom (5) Furthermore, we noted that the younger
patients were relatively more often married than the older
patients Haemophiha patients had on average less children than
men m the general population, which was partly caused by their
being less often married, and partly by genetic and physical
considerations The improved physical condition of haemophiha
patients is therefore likely to lead to an mcrease in the number of
carner daughters of haemophiha patients, and m two generations
this will cause a further mcrease in the prevalence at birth
The number of HIV positive haemophiha patients and the
ensuing mortahty differ widely from one country to another In
The Netherlands the number of infected patients is relatively low
(less than 20%) (6), and therefore the nse m the number of
patients will occur m one generation In countnes m which the
majonty of patients is HIV positive, excess mortahty may at first
lower the prevalence, but this will be a temporary effect The
attitude towards prenatal diagnosis may also be different m other
countnes Nevertheless, we thmk that the substantial growth m
prevalence per 100 000 males
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Fig l Prevalence of haemophiha by age For each age group the number
of haemophiha patients, corrected for non response, is related to the
number of individuals in that age group in the general male population
the number of haemophihacs by about 20% we foresee m The
Netherlands is likely to occur in many Western countnes The
"extra" patients will be mostly those with severe hemophiha,
since they showed the largest deficit in the older age groups
because of excess mortahty m the past
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